PALLAS: limiting indications for dronedarone treatment of atrial fibrillation?

Author： Doggrell Sheila A   Hancox Jules C  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.6, 2012-04, pp. : 867-871

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal

By McKenna Claire  

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 35-46

Adis International

Access to resources Recommend Favorite

Dronedarone rates highly for atrial fibrillation

By  

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Dronedarone: a guide to its use in atrial fibrillation

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 3, 2010-03 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Dronedarone: A New Hope for Stroke Prevention in Atrial Fibrillation?

By Shantsila Alena   Lip Gregory Y.H.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 355-356

Adis International

Access to resources Recommend Favorite

Drug safety evaluation of dronedarone in atrial fibrillation

By De Ferrari Gaetano M   Dusi Veronica  

Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. : 1023-1045

Informa Healthcare

Access to resources Recommend Favorite